Organ allocation: model for end-stage liver disease, Child-Turcotte-Pugh, Mayo risk score, or something else.
The discovery of a single test of liver function has been a goal of hepatologists for many years. The great complexity of the liver and its many diverse functions, however, has prevented such an accomplishment. An analogy can be made with the way one currently uses liver tests where several individual tests are combined into a profile. This article presents evidence that confirms the same concept: Only by combining several clinical and laboratory measures can we predict the prognosis of liver disease patients. End-stage liver disease and pediatric end-stage liver disease models are valuable additions to the prognostic armamentarium; however, these models are not perfect and some important indications for liver transplant today cannot be included because their main issue is not disease severity.
D015276:Health Care Rationing / Q000379:methods; D006801:Humans; D017093:Liver Failure / Q000601:surgery*; D008111:Liver Function Tests; D016031:Liver Transplantation; D011379:Prognosis; D009927:Tissue and Organ Procurement / Q000592:standards*; D019737:Transplants / Q000600:supply & distribution; D014850:Waiting Lists